Many people heard that Medicare started covering Wegovy, and that statement is only partly true
But the annual cost of these drugs in the US upwards of $11,000 at recent list prices, though net prices may be lower with rebates negotiated by pharmacy benefit managers has raised concerns about the fiscal impact of broad coverage of GLP-1 drugs on Medicare, other health insurers, and patients
Crizanlizumab, voxelotor, and L-glutamine for sickle cell disease: effectiveness and value
But the ketone production and metabolic state changes are real on top of that
Your gut's natural pace of digestion accelerates, and your brain's satiety centers receive weaker suppression signals, collectively reactivating appetite pathways that had been quieted by the medication